Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 1,294,189 |
|
|||||
| News | - | ||||||
| Day High | 25.055 | Low High |
|||||
| Day Low | 24.63 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Insmed Inc | INSM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.12 | -0.48% | 24.80 | 16:49:31 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 24.92 | 24.63 | 25.055 | 24.80 | 24.92 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,699 | 1,294,189 | US$ 24.87 | US$ 32,192,677 | - | 18.085 - 32.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:55:56 | 1 | US$ 24.50 | USD |
Insmed (INSM) Options Flow Summary
Insmed Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.68B | 148.49M | - | 305.21M | -749.57M | -5.05 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Insmed News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INSM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.86 | 25.955 | 23.525 | 24.73 | 2,978,910 | -0.06 | -0.24% |
| 1 Month | 26.90 | 28.71 | 23.525 | 26.14 | 2,171,915 | -2.10 | -7.81% |
| 3 Months | 28.16 | 29.91 | 23.525 | 27.04 | 1,777,242 | -3.36 | -11.93% |
| 6 Months | 25.49 | 32.00 | 23.04 | 27.15 | 1,666,922 | -0.69 | -2.71% |
| 1 Year | 18.72 | 32.00 | 18.085 | 25.20 | 1,436,922 | 6.08 | 32.48% |
| 3 Years | 35.50 | 36.97 | 16.04 | 23.75 | 1,212,166 | -10.70 | -30.14% |
| 5 Years | 29.95 | 45.44 | 12.09 | 24.81 | 1,140,970 | -5.15 | -17.20% |
Insmed Description
| Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension. |
